Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 366

1.

Negativation of type 1 diabetes-associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol.

Papadimitriou DT, Marakaki C, Fretzayas A, Nicolaidou P, Papadimitriou A.

J Diabetes. 2013 Sep;5(3):344-8. doi: 10.1111/1753-0407.12023. Epub 2013 May 29.

PMID:
23302101
2.

[Autoantibodies to GAD65, IA2 and insulin in Czech children with type 1 diabetes].

Cinek O, Pechová M, Kolousková S, Horká I, Sedláková P, Sumník Z, Snajderová M, Vavrinec J.

Cas Lek Cesk. 2000 Sep 27;139(19):599-603. Czech.

PMID:
11192752
3.

Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.

Yamamoto AM, Deschamps I, Garchon HJ, Roussely H, Moreau N, Beaurain G, Robert JJ, Bach JF.

J Autoimmun. 1998 Dec;11(6):643-50.

PMID:
9878086
4.

The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.

Jaeger C, Hatziagelaki E, Stroedter A, Becker F, Scherer S, Petzoldt R, Federlin K, Bretzel RG.

Exp Clin Endocrinol Diabetes. 1999;107(8):496-505.

PMID:
10612480
5.

Antigenic determinants to GAD autoantibodies in patients with type 1 diabetes with and without autoimmune thyroid disease.

Park H, Yu L, Kim T, Cho B, Kang J, Park Y.

Ann N Y Acad Sci. 2006 Oct;1079:213-9.

PMID:
17130557
6.
7.

Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.

Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR.

Diabet Med. 1997 Aug;14(8):678-85.

PMID:
9272595
8.

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

Metabolism. 2003 Jan;52(1):25-9.

PMID:
12524658
9.

Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.

Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG.

Diabetologia. 1998 May;41(5):536-41.

PMID:
9628270
10.

'Insulin autoantibody affinity measurement using a single concentration of unlabelled insulin competitor discriminates risk in relatives of patients with type 1 diabetes.

Curnock RM, Reed CR, Rokni S, Broadhurst JW, Bingley PJ, Williams AJ.

Clin Exp Immunol. 2012 Jan;167(1):67-72. doi: 10.1111/j.1365-2249.2011.04495.x.

11.
12.

Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.

Mortensen HB, Swift PG, Holl RW, Hougaard P, Hansen L, Bjoerndalen H, de Beaufort CE, Knip M; Hvidoere Study Group on Childhood Diabetes.

Pediatr Diabetes. 2010 Jun;11(4):218-26. doi: 10.1111/j.1399-5448.2009.00566.x. Epub 2008 Aug 25.

PMID:
19708904
13.

Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.

Andersson C, Carlsson A, Cilio C, Cedervall E, Ivarsson SA, Jonsdottir B, Jönsson B, Larsson K, Neiderud J, Lernmark A, Elding Larsson H; DiAPREV-IT Study Group.

Pediatr Diabetes. 2013 Aug;14(5):341-9. doi: 10.1111/pedi.12023. Epub 2013 Mar 8.

PMID:
23469940
14.

Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes.

Giannopoulou EZ, Winkler C, Chmiel R, Matzke C, Scholz M, Beyerlein A, Achenbach P, Bonifacio E, Ziegler AG.

Diabetologia. 2015 Oct;58(10):2317-23. doi: 10.1007/s00125-015-3672-y. Epub 2015 Jul 3.

PMID:
26138334
15.

Role of insulin autoantibody affinity as a predictive marker for type 1 diabetes in young children with HLA-conferred disease susceptibility.

Siljander H, Härkönen T, Hermann R, Simell S, Hekkala A, Salonsaari RT, Simell T, Simell O, Ilonen J, Veijola R, Knip M.

Diabetes Metab Res Rev. 2009 Oct;25(7):615-22. doi: 10.1002/dmrr.998.

PMID:
19637309
16.

Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2beta predict immune-mediated (Type 1) diabetes in relatives.

Maclaren N, Lan M, Coutant R, Schatz D, Silverstein J, Muir A, Clare-Salzer M, She JX, Malone J, Crockett S, Schwartz S, Quattrin T, DeSilva M, Vander Vegt P, Notkins A, Krischer J.

J Autoimmun. 1999 Jun;12(4):279-87.

PMID:
10330299
17.

Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, Steck A, Winkler C, Ilonen J, Veijola R, Knip M, Bonifacio E, Eisenbarth GS.

JAMA. 2013 Jun 19;309(23):2473-9. doi: 10.1001/jama.2013.6285.

18.

Higher prevalence of autoantibodies to insulin and GAD65 in Swedish compared to Lithuanian children with type 1 diabetes.

Holmberg H, Vaarala O, Sadauskaite-Kuehne V, Ilonen J, Padaiga Z, Ludvigsson J.

Diabetes Res Clin Pract. 2006 Jun;72(3):308-14. Epub 2006 Jan 26.

PMID:
16442659
19.

The broad clinical phenotype of Type 1 diabetes at presentation.

Merger SR, Leslie RD, Boehm BO.

Diabet Med. 2013 Feb;30(2):170-8. doi: 10.1111/dme.12048. Review.

PMID:
23075321
20.

IA-2 autoantibodies predict impending type I diabetes in siblings of patients.

Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Weets I, Vandemeulebroucke E, Truyen I, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

Diabetologia. 2002 Dec;45(12):1658-66. Epub 2002 Nov 12.

PMID:
12488955

Supplemental Content

Support Center